Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flucloxacillin absorption test prediction study
NL-OMON55269Recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of flucloxacillin in Staphylococcus aureus infection, sponsored by Haaglanden Medical Centre. Primary endpoints: Prediction of time above MIC using 3-point concentration curves and Prediction of time above MIC using 7-point concentration curves. Started Feb 2021; status: recruiting.
02
Drugs
flucloxacillin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NL-OMON55269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55269.